Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Rossi

Showing results (91-100 of 173) with videos related to

Pageof 18
Sort By:
Dermatology Reports|December 9, 2022
Guselkumab for the treatment of severe plaque psoriasis in a schizophrenia patientNicoletta Bernardini, Nevena Skroza, Elisabeth Prevete, et al.
Expert Opinion on Pharmacotherapy|November 6, 2018
Afatinib and Erlotinib in the treatment of squamous-cell lung cancerMarco Tagliamento, Carlo Genova, Erika Rijavec, et al.
Dermatologic Therapy|January 31, 2022
Psoriatic patients with a history of cancer: A real-life experience with Apremilast treatment for 104 weeksNicoletta Bernardini, Nevena Skroza, Anna Marchesiello, et al.
Expert Opinion on Pharmacotherapy|November 15, 2016
New systemic strategies for overcoming resistance to targeted therapies in non-small cell lung cancerCarlo Genova, Erika Rijavec, Federica Biello, et al.
Le Infezioni in Medicina|February 27, 2004
Hepatitis viruses and HIV infection in the Naples areaPietro Filippini, Nicola Coppola, Carlo Scolastico, et al.
Expert Opinion on Pharmacotherapy|October 26, 2018
The evolving role of pemetrexed disodium for the treatment of non-small cell lung cancerGiovanni Rossi, Angela Alama, Carlo Genova, et al.
Leukemia Research|December 27, 2011
Comparison between multiparameter flow cytometry and WT1-RNA quantification in monitoring minimal residual disease in acute myeloid leukemia without specific molecular targetsGiovanni Rossi, Maria Marta Minervini, Angelo Michele Carella, et al.
Expert Opinion on Pharmacotherapy|February 20, 2020
ADP ribose polymerase inhibitors for treating non-small cell lung cancer: new additions to the pharmacotherapeutic armamentariumGiovanni Rossi, Lodovica Zullo, Luigi Cerbone, et al.
Frontiers in Oncology|November 13, 2025
Immune-related osteitis mimicking femoral head osteonecrosis during dual checkpoint blockade: a case reportEnrica Teresa Tanda, Agostina Lagodin D'Amato, Giovanni Rossi, et al.
Dermatology Reports|December 9, 2022
Long term efficacy, safety, and tolerability of tildrakizumab in epileptic patient with psoriasis and eczemaNicoletta Bernardini, Nevena Skroza, Giovanni Rossi, et al.
Pageof 18

Showing results (91-100 of 173) with videos related to

Sort By:
Pageof 18
Dermatology Reports|December 9, 2022
Guselkumab for the treatment of severe plaque psoriasis in a schizophrenia patientNicoletta Bernardini, Nevena Skroza, Elisabeth Prevete, et al.
Expert Opinion on Pharmacotherapy|November 6, 2018
Afatinib and Erlotinib in the treatment of squamous-cell lung cancerMarco Tagliamento, Carlo Genova, Erika Rijavec, et al.
Dermatologic Therapy|January 31, 2022
Psoriatic patients with a history of cancer: A real-life experience with Apremilast treatment for 104 weeksNicoletta Bernardini, Nevena Skroza, Anna Marchesiello, et al.
Expert Opinion on Pharmacotherapy|November 15, 2016
New systemic strategies for overcoming resistance to targeted therapies in non-small cell lung cancerCarlo Genova, Erika Rijavec, Federica Biello, et al.
Le Infezioni in Medicina|February 27, 2004
Hepatitis viruses and HIV infection in the Naples areaPietro Filippini, Nicola Coppola, Carlo Scolastico, et al.
Expert Opinion on Pharmacotherapy|October 26, 2018
The evolving role of pemetrexed disodium for the treatment of non-small cell lung cancerGiovanni Rossi, Angela Alama, Carlo Genova, et al.
Leukemia Research|December 27, 2011
Comparison between multiparameter flow cytometry and WT1-RNA quantification in monitoring minimal residual disease in acute myeloid leukemia without specific molecular targetsGiovanni Rossi, Maria Marta Minervini, Angelo Michele Carella, et al.
Expert Opinion on Pharmacotherapy|February 20, 2020
ADP ribose polymerase inhibitors for treating non-small cell lung cancer: new additions to the pharmacotherapeutic armamentariumGiovanni Rossi, Lodovica Zullo, Luigi Cerbone, et al.
Frontiers in Oncology|November 13, 2025
Immune-related osteitis mimicking femoral head osteonecrosis during dual checkpoint blockade: a case reportEnrica Teresa Tanda, Agostina Lagodin D'Amato, Giovanni Rossi, et al.
Dermatology Reports|December 9, 2022
Long term efficacy, safety, and tolerability of tildrakizumab in epileptic patient with psoriasis and eczemaNicoletta Bernardini, Nevena Skroza, Giovanni Rossi, et al.
Pageof 18